• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Talia Puzantian, PharmD, BCPP

Articles by Talia Puzantian, PharmD, BCPP

Clinical Update

Pain and Opioid Use in Older Adults

July 1, 2025
Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Shireen Wissa, PharmD candidate. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Age-related changes affect opioid metabolism and increase fall risk in older adults. Learn evidence-based approaches to pain management, safer prescribing practices, and deprescribing strategies while managing drug interactions and side effects.


Read More
Risks in Older Adults

Insomnia and Sleep Medications

April 1, 2025
Talia Puzantian, PharmD, BCPP and Shireen Wissa, PharmD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Shireen Wissa, PharmD candidate and Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Examining the long-term impacts of common sleep aids in older adults should urge a rethinking of prescribing practices.


Read More
News of Note

News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment

October 1, 2024
Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.

The FDA recently approved donanemab for early Alzheimer’s, offering new hope by slowing cognitive decline.


Read More
Clinical Update

Considerations in Prescribing Lithium in Older Adults

October 1, 2024
Shireen Wissa, PharmD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Shireen Wissa, PharmD Candidate 2025. Keck Graduate Institute School of Pharmacy, Claremont, CA.

Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, ­Claremont, CA.

Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.

Smart dosing and vigilant monitoring can turn the often-feared lithium into a safe, effective solution for older adults.


Read More
Risks in Older Adults

Antidepressants and Hyponatremia

April 1, 2024
Heather Robles, PharmD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Heather Robles, PharmD candidate, and Talia Puzantian, PharmD, BCPP. Ms. Robles and Dr. Puzantian have no financial relationships with companies related to this material.

A brief review of hyponatremia including medications that cause it, symptoms to look out for, and how to prevent and treat this common side effect.


Read More
News of Note

Brexpiprazole

October 31, 2023
Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material. 

Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease. 


Read More
EXPERT Q&A

Buprenorphine and Dental Issues

January 30, 2023
Talia Puzantian, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

 Abelleira_Headshot_CATR.jpgTalia Puzantian, PharmD, BCPP.

Deputy editor for The Carlat Addiction Treatment Report. Professor, Keck Graduate Institute School of Pharmacy. Claremont, CA.

Dr. Puzantian has no financial relationships with companies related to this material.

Buprenorphine is a first line treatment for opioid use disorder and has saved countless lives, but new warnings about associations between certain buprenorphine formulations and dental problems have people worried. Here, Dr. Puzantian reviews the data and shows us how to apply this new information to clinical care.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023).

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More
Previous 1 2 3 4 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • GFB1e_Spiral.png

    Geriatric Psychiatry Fact Book, First Edition (2025)

    Everything you need to help your older adult patients from the unbiased clinical experts who...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2669706505.jpg
    General Psychiatry

    A New Ketamine

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.